What should the medical laboratory scientist do when a nurse requests to take 50 mcg from a 300 mcg syringe of RhIg?

What should the medical laboratory scientist do when a nurse requests to take 50 mcg from a 300 mcg syringe of RhIg?

• A. Let the nurse take the syringe of RhIg
• B. Call a supervisor or pathologist
• C. Instruct the nurse that the blood bank does not stock minidoses of RhIg
• D. Instruct the nurse and relay this information to the patient's physician

Answer: (D)

In situations involving the administration of Rh immunoglobulin (RhIg), it is essential for the medical laboratory scientist to ensure that strict protocols and guidelines are followed to maintain patient safety and regulatory compliance. When a nurse requests to take 50 mcg from a 300 mcg syringe of RhIg, the correct action involves instructing the nurse on the proper procedures for administering this medication. When responding, the medical laboratory scientist should provide clear guidance about the appropriate handling and administration practices of RhIg. This may include explaining the importance of dosing, the risk of contamination, and the considerations for storing the medication safely. Furthermore, it is crucial to relay this information to the patient's physician. This collaborative communication ensures that all parties involved in patient care are aware of the medication being administered and can coordinate effectively. By taking this approach, it not only safeguards the integrity of the RhIg but also fosters a culture of teamwork among healthcare professionals, enhancing patient outcomes. Such actions underscore the responsibilities of laboratory professionals in ensuring the safe use of blood products and adherence to established protocols in transfusion medicine.

In situations involving the administration of Rh immunoglobulin (RhIg), it is essential for the medical laboratory scientist to ensure that strict protocols and guidelines are followed to maintain patient safety and regulatory compliance. When a nurse requests to take 50 mcg from a 300 mcg syringe of RhIg, the correct action involves instructing the nurse on the proper procedures for administering this medication.

When responding, the medical laboratory scientist should provide clear guidance about the appropriate handling and administration practices of RhIg. This may include explaining the importance of dosing, the risk of contamination, and the considerations for storing the medication safely. Furthermore, it is crucial to relay this information to the patient's physician. This collaborative communication ensures that all parties involved in patient care are aware of the medication being administered and can coordinate effectively.

By taking this approach, it not only safeguards the integrity of the RhIg but also fosters a culture of teamwork among healthcare professionals, enhancing patient outcomes. Such actions underscore the responsibilities of laboratory professionals in ensuring the safe use of blood products and adherence to established protocols in transfusion medicine.